This site might not work as expected.
You're using an old browser that isn't supported by this site. Please upgrade or download one of these free and excellent browsers: https://browser-update.org/update.html

Wolters Kluwer Debuts New Face of Its Clinical Drug Information Unit

Launch of New Website Establishes Clinical Drug Information as a Single Provider offering Lexicomp, Medi-Span and Facts & Comparisons Solutions

Wolters Kluwer, a leading global provider of information for healthcare professionals and students, announced today the launch of a new website, social media identity, and overall rebrand of its Clinical Drug Information unit, positioning it as the single provider of aligned medication decision support solutions from its three industry-leading applications, Lexicomp®, Medi-Span®, and Facts & Comparisons®.

The Clinical Drug Information mission is to support, strengthen, and inform healthcare professionals to help their smart medication decisions become brilliant. In short: When it comes to drug information, we have you covered.

The newly-launched Clinical Drug Information presence includes:

From 1989-2011, Wolters Kluwer strategically acquired some of the industry's most respected and trusted drug information brands in order to build an unprecedented and unparalleled content source, uniting the strengths, experience, expertise, and innovations of its acquisitions. By integrating and aligning the content, functionality, and technology of Lexicomp, Medi-Span, and Facts & Comparisons, Wolters Kluwer Clinical Drug Information has created a complementary suite of resources that encompasses drug reference information (online, mobile, and books), drug databases and integrated tools to power EMRs, pharmacy applications, and other healthcare systems. To learn more, view this video.

The new website allows healthcare professionals and organizations to explore drug reference and drug data solutions, including drug dosing and administration, pediatric and neonatal drug information, drug interactions and allergies, formulary management, alert management, drug pricing, Medication Therapy Management (MTM), pharmacogenomics, dental drug information, standard vocabularies for interoperability, patient education, and more. The website also provides:

  • Detailed focus on the clinical, commercial, and international markets Clinical Drug Information serves
  • Webstore for individual purchase of mobile apps, books, and more
  • The RxPerts Academy, including the popular Clinical Drug Information free educational webinar series and other articles by thought leaders on trending healthcare topics (Coming Soon!)

"For years, the healthcare industry has trusted Medi-Span, Facts & Comparisons, and Lexicomp to help professionals provide safer drug therapies and operate efficiently. Now, we want our customers, partners, and professionals around the world to view those three great applications as a single drug information solution, working in concert to support drug-related decision making," stated Steven Kerscher, Vice President & General Manager, Clinical Drug Information, Wolters Kluwer Health, Clinical Solutions. "As we continue to develop consistent content and functionality across all three applications, our customers will experience improved communication and workflow, a reduction in medication errors, and an overall enhancement of patient care. With all of these solutions, content experts, and technological innovators operating as a single unit, we have you covered!"

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.